Onc Now | Episode 8
In this episode of Onc Now, Jonathan welcomes Ahmad Awada, Head of the Oncology Department at Chirec Cancer Institute in Brussels and Editor in Chief of EMJ Oncology. Together they discuss groundbreaking developments in cancer care, the promise of targeted therapies, and the importance of global collaboration in oncology.
Spotify | Apple | Amazon Music | Download MP3 (31 mins)
Ahmad Awada is Head of the Oncology Department and Director of Chirec Cancer Institute, Brussels, Belgium, and is a global leader in oncology, specialising in the development of new drugs for cancer treatment.
With a medical degree from Université Libre de Bruxelles and advanced training in the Netherlands and the USA, his work has significantly advanced the understanding of cytotoxic and targeted therapies for solid tumours.
Timestamps:
00:00 – Introduction
01:20 – Reflecting on ESMO 2024
07:37 – Looking ahead to ESMO 2025
10:04 – Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates
13:24 – New cytotoxics and molecular targeted therapies for solid tumours
16:30 – Surgery of primary tumour in de novo metastatic breast cancer
19:29 – Improving survival in cancer patients
22:47 – Managing the risk of thromboembolism
24:43 – Exciting advancements on the horizon
29:38 – Wishes for oncology
